Raw Powder Thiamphenicol Raw Material Thiamphenicol Powder Veterinary Powder Thiamphenicol

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Model NO.: D-sung-Vidarabine
• Product Name: Vidarabine
• Name: Vidarabine Powder
• Appearance: White Powder
• Color: White Color
• Grade: Pharmacuetical Grade
• Assay: HPLC 99%
• Application: Pharmacuetical Grade
• Specific: COA
• Test Method: HPLC UV
• CAS: 5536-17-4
• Mf: C10h13n5o4
• MW: 267.24132
• Einecs: 226-893-9
• Hc: 29349990
• Boiling Point: 676.3
• Transport Package: Negotiabie
• Specification: 99%
• Trademark: D-sung
• Origin: Xi′an Shaanxi
• Production Capacity: 5000kg/Month

Product Description

Raw Powder Thiamphenicol Raw Material Thiamphenicol Powder Veterinary Powder Thiamphenicol

Product Description

Product Datails

Product Name	Vidarabine
CAS NO.	5536-17-4
Purity	99%
Melting Point	260-265 C (dec.)
Appearance and shape	White powder

Vidarabine is an aminoalcohol. Amines are chemical bases. They neutralize acids to form salts plus water. These acid-base reactions are exothermic. The amount of heat that is evolved per mole of amine in a neutralization is largely independent of the strength of the amine as a base. Amines may be incompatible with isocyanates, halogenated organics, peroxides, phenols

Application&Function

1. Antiarrhythmic drugs can turn paroxysmal supraventricular tachycardia into sinus rhythm. For supraventricular arrhythmias associated with atrioventricles.

2. Antiviral drugs.

3. In the pharmaceutical industry, it is mainly used to produce the main raw materials of drugs such as adenosine arabinose, adenosine triphosphate, coenzyme and its series products adenosine cyclophosphate.

4. Used in the manufacture of ATP, adenosine arabinose, coenzyme A, etc. 5. Treatment of angina pectoris, myocardial infarction, coronary insufficiency, arteriosclerosis, essential hypertension, cerebrovascular disorders, sequelae of stroke, progressive muscle atrophy, etc. Atrioventricular block and acute myocardial infarction are prohibited.

Specification